Ambarish Pandey

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Roche
    Topic:
    Advisor for Biomarkers in diabetes, received compensation as an advisor and speaker
    Date added:
    10/24/2022
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Tricog Health
    Topic:
    Research advisor
    Date added:
    10/24/2022
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Lilly USA
    Topic:
    Executive committee member for trial
    Date added:
    10/24/2022
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Rivus
    Topic:
    Advisor
    Date added:
    10/24/2022
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Novo Nordisk
    Topic:
    Advisor
    Date added:
    02/15/2024
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Merck
    Topic:
    Adjudication committee for trial
    Date added:
    02/15/2024
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Medtronic
    Topic:
    Advisor
    Date added:
    02/15/2024
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Edward Lifesciences
    Topic:
    Advisor
    Date added:
    02/15/2024
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Axon Therapies
    Topic:
    Advisor
    Date added:
    02/15/2024
    Date updated:
    12/15/2025
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Ultromics
    Topic:
    Advisor
    Date added:
    02/15/2024
    Date updated:
    12/15/2025

Pages

Return to 102 Cardiology Clinical Conference (FY26) "Management of CAD and TAVR: Rethinking the Reflex" & "Biomarker Guided Approach for Heart Failure Prevention in Diabetes" (060326)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.